• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

BioSphere Medical to Present at C.E. Unterberg, Towbin Life Sciences Conference

Posted on: Tuesday, 18 October 2005, 09:01 CDT

BioSphere Medical, Inc. (NASDAQ: BSMD), a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a procedure called embolization announced today that Richard Faleschini, President and Chief Executive Officer will be presenting an overview of the Company at the C.E. Unterberg, Towbin Life Sciences Conference in New York on Tuesday, October 25, 2005 at 9:20 am Eastern Time. The conference is being held at the New York Palace Hotel.

The presentation will also be broadcast live over the Internet via the investor events page of the BioSphere Medical website - www.biospheremed.com. To listen to the live call, go to the website at least 15 minutes early to register, download and install any necessary audio software. Access to the webcast will be available for seven days following the presentation as a replay at http://www.wsw.com/webcast/ceut3/bsmd/.

About BioSphere Medical, Inc.

BioSphere Medical, Inc., a medical device company based in Rockland, Massachusetts, seeks to pioneer and commercialize minimally invasive diagnostic and therapeutic applications based on proprietary bioengineered microsphere technology. The Company's core technologies, patented bioengineered polymers and manufacturing methods, are used to produce microscopic spherical materials with unique beneficial properties for a variety of medical applications. BioSphere's principal focus is the treatment of symptomatic uterine fibroids using a procedure called uterine fibroid embolization, or UFE. The Company's products continue to gain acceptance in this rapidly emerging procedure as well as in a number of other new and established medical treatments.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. For a discussion of important risks and uncertainties which could cause actual results to differ from those contained in such forward-looking statements, see "Factors That May Affect Future Results" in the Company's Annual Report or Form 10-K for the period ending December 31, 2004, and Form 10-Q for the period ending June 30, 2005, as well as other filings that the Company makes with the SEC. The forward-looking statements in this press release are made as of the date of this press release and the Company disclaims any obligation to update these forward-looking statements as a result of changed events, circumstances or otherwise.

Source: Business Wire

More News in this Category